Epidemiology and Acute Oral Effects Electronic Cigarette
NCT ID: NCT03011710
Last Updated: 2023-11-29
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
14 participants
INTERVENTIONAL
2015-09-30
2023-11-22
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
The benefits and risks of electronic cigarette use are uncertain. There is no research on the acute oral effects of electronic cigarette in the scientific literature and no hungarian epidemiological survey has been performed in this topic.
Regulation of electronic cigarettes varies across countries in the European Union, ranging from no regulation to banning them entirely.
The investigators research could help to integrate the regulation of this device in Hungary and in the EU as well.
The measurement of acute oral effects of e-cigarette and a hungarian epidemiological survey would be novel in this topic.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The main outcome of interest was whether or not e-cigarette use helped people to quit smoking or reduce the number of conventional cigarettes. Participants were also asked about the reason for starting e-cigarette use. Nationality, habitation, citizenship status were included as demographic predictors in analyses.
Measurements of acute oral effects before and after using electronic cigarette with nicotine, without nicotine, conventional cigarette and placebo device:
* measurement of exhaled CO changes by Smokerlyzer piCO
* measurement of saliva MMP-8 by PerioSafe Home
* measurement of saliva pH, buffering capacity, and flow rate changes by Saliva Check Buffer Kit (GC)
* measurement of oral mucosal blood flow changes by Perilam PSI System High Resolution (LASCA method)
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
NON_RANDOMIZED
PARALLEL
BASIC_SCIENCE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
E-cigarette with nicotine
Nicotine level: 6 mg/ml
ProVari v2.5 (E-cigarette)
An electronic cigarette or e-cigarette is a handheld electronic device that vaporizes a flavored liquid. The user inhales the vapor. The fluid in the e-cigarette, called e-liquid, is usually made of nicotine, propylene glycol, glycerine, and flavorings.
E-cigarette without nicotine
Nicotine level: 0 mg/ml
ProVari v2.5 (E-cigarette)
An electronic cigarette or e-cigarette is a handheld electronic device that vaporizes a flavored liquid. The user inhales the vapor. The fluid in the e-cigarette, called e-liquid, is usually made of nicotine, propylene glycol, glycerine, and flavorings.
Conventional cigarette
Nicotine content: 0,5mg
Marlboro Gold (Conventional cigarette)
Conventional cigarette
Cigarette tip
Placebo device
Cigarette tip
Placebo device
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
ProVari v2.5 (E-cigarette)
An electronic cigarette or e-cigarette is a handheld electronic device that vaporizes a flavored liquid. The user inhales the vapor. The fluid in the e-cigarette, called e-liquid, is usually made of nicotine, propylene glycol, glycerine, and flavorings.
Marlboro Gold (Conventional cigarette)
Conventional cigarette
Cigarette tip
Placebo device
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* signed consent form
* smoking regularly e-cigarette and/or conventional cigarette for \> half year
Exclusion Criteria
* BMI index \< 30
* no severe parodontal disease
* no acute illness in the last 2 weeks
* no chronic disease (eg.: diabetes)
* no diet which can influence the oral pH
19 Years
49 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Semmelweis University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
epidacute-ecig-2015
Identifier Type: -
Identifier Source: org_study_id